These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Uridine in the prevention and treatment of NRTI-related mitochondrial toxicity. Walker UA; Venhoff N Antivir Ther; 2005; 10 Suppl 2():M117-23. PubMed ID: 16152713 [TBL] [Abstract][Full Text] [Related]
4. Stavudine in antiretroviral therapy: is this the end? Brinkman K AIDS; 2009 Aug; 23(13):1727-9. PubMed ID: 19571724 [No Abstract] [Full Text] [Related]
5. Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy. Shah SS; Rodriguez T; McGowan JP Clin Infect Dis; 2003 May; 36(10):e131-3. PubMed ID: 12746793 [TBL] [Abstract][Full Text] [Related]
6. Replacing stavudine by abacavir reduces lactate levels and may improve lipoatrophy. García-Benayas T; Blanco F; de la Cruz JJ; Soriano V; González-Lahoz J AIDS; 2003 Apr; 17(6):921-4. PubMed ID: 12660543 [No Abstract] [Full Text] [Related]
7. Occurrence of stavudine-induced lactic acidosis in 3 members of an African family. Fielder J; Rambiki K J Int Assoc Physicians AIDS Care (Chic); 2010; 9(4):236-9. PubMed ID: 20798404 [TBL] [Abstract][Full Text] [Related]
8. Stavudine-induced macrocytosis during therapy for human immunodeficiency virus infection. Martin GJ; Blazes DL; Mayers DL; Spooner KM Clin Infect Dis; 1999 Aug; 29(2):459-60. PubMed ID: 10476771 [No Abstract] [Full Text] [Related]
9. Puerperal febrile morbidity associated with the reverse transcriptase inhibitor stavudine. Wax JR; Mueller S J Matern Fetal Med; 1997; 6(2):118-9. PubMed ID: 9086430 [TBL] [Abstract][Full Text] [Related]
10. Lamivudine-stavudine-induced liver failure in hepatitis B cirrhosis. Schiano TD; Lissoos TW; Ahmed A; Siano C; Zaitman D; Cohn G; Ehrenpreis ED Am J Gastroenterol; 1997 Sep; 92(9):1563-4. PubMed ID: 9317091 [No Abstract] [Full Text] [Related]
11. Long-term safety and efficacy of nevirapine, stavudine and lamivudine in a real-world setting. Shalit P; Farrell P; Lindgren P AIDS; 2001 Apr; 15(6):804-5. PubMed ID: 11371699 [No Abstract] [Full Text] [Related]
12. Symptomatic hyperlactatemia in an HIV-positive patient: a case report and discussion. Antoniou T; Weisdorf T; Gough K CMAJ; 2003 Jan; 168(2):195-8. PubMed ID: 12538549 [TBL] [Abstract][Full Text] [Related]
13. Complete reversibility of severe nucleoside-induced lipodystrophy. Strobel M; Muller P; Claudel P AIDS; 1999 Dec; 13(18):2606-7. PubMed ID: 10630538 [No Abstract] [Full Text] [Related]
14. Lactic acidosis secondary to nucleoside analogue antiretroviral therapy. Khouri S; Cushing H AIDS Read; 2000 Oct; 10(10):602-6. PubMed ID: 11068807 [TBL] [Abstract][Full Text] [Related]
15. Lactic acidosis associated with stavudine administration: a report of five cases. Mokrzycki MH; Harris C; May H; Laut J; Palmisano J Clin Infect Dis; 2000 Jan; 30(1):198-200. PubMed ID: 10619755 [TBL] [Abstract][Full Text] [Related]
16. Excess peripheral neuropathy in patients treated with hydroxyurea plus didanosine and stavudine for HIV infection. Cepeda JA; Wilks D AIDS; 2000 Feb; 14(3):332-3. PubMed ID: 10716516 [No Abstract] [Full Text] [Related]